21263193|t|Antidepressants modulate intracellular amyloid peptide species in N2a neuroblastoma cells.
21263193|a|It is estimated that 30%-50% of Alzheimer's disease (AD) patients are diagnosed with major or minor depression. Research that addresses the relationship between these two diseases will benefit patients who suffer from depression comorbid with AD and allow further understanding of the neuroanatomy of depression. A clinical study showed that the use of the antidepressant fluoxetin concomitantly with the FDA-approved AD drug rivastigmine provided an improvement in the daily activities and the overall functioning in the patients with cognitive impairment. In an attempt to understand the underlying mechanism for the antidepressant's beneficial effect in AD patients, we evaluated the effects of different classes of antidepressants on the amyloid-beta peptide (Abeta) species in N2a neuroblastoma cells overexpressing amyloid-beta protein precursor. The effect of increasing antidepressant concentrations on the intracellular and secreted Abeta species is investigated by Western blotting. The tested antidepressants include fluoxetine, paroxetine, maprotiline, and imipramine. Fluoxetine and paroxetine at 10 muM significantly decreased the intracellular level of Abeta oligomers and increased the level of Abeta monomers. However, imipramine and maprotiline increased the intracellular amount of Abeta monomers without affecting Abeta oligomers. Based on these results, it is possible that fluoxetine and paroxetine could be beneficial to AD patients via reducing the level of the cytotoxic oligomers and keeping the Abeta peptide in the monomeric form. These data could explain some of the beneficial effects of antidepressants in AD patients observed in clinical studies.
21263193	39	62	amyloid peptide species	Chemical	-
21263193	66	83	N2a neuroblastoma	CellLine	CVCL:1606
21263193	123	142	Alzheimer's disease	Disease	MESH:D000544
21263193	144	146	AD	Disease	MESH:D000544
21263193	148	156	patients	Species	9606
21263193	176	201	major or minor depression	Disease	MESH:D003865
21263193	284	292	patients	Species	9606
21263193	309	319	depression	Disease	MESH:D003866
21263193	334	336	AD	Disease	MESH:D000544
21263193	392	402	depression	Disease	MESH:D003866
21263193	463	472	fluoxetin	Chemical	MESH:D005473
21263193	509	511	AD	Disease	MESH:D000544
21263193	517	529	rivastigmine	Chemical	MESH:D000068836
21263193	613	621	patients	Species	9606
21263193	627	647	cognitive impairment	Disease	MESH:D003072
21263193	748	750	AD	Disease	MESH:D000544
21263193	751	759	patients	Species	9606
21263193	855	860	Abeta	Gene	11820
21263193	873	890	N2a neuroblastoma	CellLine	CVCL:1606
21263193	1033	1038	Abeta	Gene	351
21263193	1119	1129	fluoxetine	Chemical	MESH:D005473
21263193	1131	1141	paroxetine	Chemical	MESH:D017374
21263193	1143	1154	maprotiline	Chemical	MESH:D008376
21263193	1160	1170	imipramine	Chemical	MESH:D007099
21263193	1172	1182	Fluoxetine	Chemical	MESH:D005473
21263193	1187	1197	paroxetine	Chemical	MESH:D017374
21263193	1259	1264	Abeta	Gene	351
21263193	1302	1307	Abeta	Gene	351
21263193	1327	1337	imipramine	Chemical	MESH:D007099
21263193	1342	1353	maprotiline	Chemical	MESH:D008376
21263193	1392	1397	Abeta	Gene	351
21263193	1425	1430	Abeta	Gene	351
21263193	1486	1496	fluoxetine	Chemical	MESH:D005473
21263193	1501	1511	paroxetine	Chemical	MESH:D017374
21263193	1535	1537	AD	Disease	MESH:D000544
21263193	1538	1546	patients	Species	9606
21263193	1577	1586	cytotoxic	Disease	MESH:D064420
21263193	1613	1618	Abeta	Gene	351
21263193	1728	1730	AD	Disease	MESH:D000544
21263193	1731	1739	patients	Species	9606
21263193	Negative_Correlation	MESH:D005473	MESH:D003866
21263193	Negative_Correlation	MESH:D017374	MESH:D064420
21263193	Negative_Correlation	MESH:D017374	MESH:D000544
21263193	Negative_Correlation	MESH:D007099	MESH:D003866
21263193	Negative_Correlation	MESH:D005473	MESH:D000544
21263193	Negative_Correlation	MESH:D017374	351
21263193	Negative_Correlation	MESH:D000068836	MESH:D005473
21263193	Negative_Correlation	MESH:D005473	MESH:D064420
21263193	Negative_Correlation	MESH:D000068836	MESH:D000544
21263193	Negative_Correlation	MESH:D005473	MESH:D003072
21263193	Negative_Correlation	MESH:D000068836	MESH:D003072
21263193	Negative_Correlation	MESH:D008376	MESH:D003866
21263193	Negative_Correlation	MESH:D005473	351

